Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
about
Controlled Drug Release from Pharmaceutical NanocarriersTracking of magnetite labeled nanoparticles in the rat brain using MRIPre-Assembly of Near-Infrared Fluorescent Multivalent Molecular Probes for Biological ImagingFolate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationMultifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Insight into nanoparticle cellular uptake and intracellular targetingTargeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancerLow density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsExperimental and theoretical investigations in stimuli responsive dendrimer-based assemblies.High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.Relating surface-enhanced Raman scattering signals of cells to gold nanoparticle aggregation as determined by LA-ICP-MS micromapping.Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.Nanoparticle-based technologies for retinal gene therapyGalactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.Ginger-derived nanoparticles protect against alcohol-induced liver damage.Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma TherapyThe Flip-Flop Diffusion Mechanism across Lipids in a Hybrid Bilayer MembraneCellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.Functional transformations of bile acid transporters induced by high-affinity macromolecules.Smart Mesoporous Nanomaterials for Antitumor Therapy.Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicityExploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies.Design of chitosan-based nanoformulations for efficient intracellular release of active compounds.Micro- and nanotechnologies for intracellular delivery.Learning from biology: synthetic lipoproteins for drug delivery.Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures.Cellular uptake and intracellular trafficking of oligonucleotidesHyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Single-cell mechanogenetics using monovalent magnetoplasmonic nanoparticles.Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers.Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.Oseltamivir-conjugated polymeric micelles prepared by RAFT living radical polymerization as a new active tumor targeting drug delivery platform.Bioinspired Nano-Prodrug with Enhanced Tumor Targeting and Increased Therapeutic Efficiency.In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.Nanoparticle-based targeted gene therapy for lung cancer.
P2860
Q28257050-3CE8FA2B-82F7-44CC-B05F-6AC781248665Q28540929-81C05A03-471C-4D21-904A-A0FE5F2B79F2Q28829172-BC222902-455A-42AB-8D00-2CD405C8417FQ28829561-FA29DCCF-741D-4784-B8AB-D4508FC821BEQ33612179-3B097FDE-51FB-4F6B-A18E-050C13B26369Q34127625-32E33C79-F0C9-4039-B01B-7B9DE18FED59Q34139484-87ED9A4F-247A-44F6-BB1A-0E80FC7B6BD4Q34800220-19971A2F-F3A6-4203-9101-E6A490B5DCF9Q35107030-B1AEE75A-99EC-4571-BB17-E4D55C64C2B8Q35131115-2D6A5E08-079B-44BC-93D3-20FD61ACD3C2Q35224251-B640B0C2-019E-488D-8984-0B8873FA10A2Q35284235-C3482891-F134-40D7-B5CD-1591AB37EB19Q35483911-F4F751BD-686D-4D2A-BF4B-27C927E37D07Q35843512-11FF38F1-77F0-4455-850D-C200B31A1355Q36172753-A0CB73D0-BB1C-421E-BACB-A6269E7C8F14Q36325163-EBE90887-4DC8-4D67-88D2-C775FA061672Q36510844-7D5507E6-94D8-49F3-B073-0E5D12CF1801Q37041954-2809BB17-9012-4E7B-8D66-17F172D78FAFQ37214592-EFE4937F-EAF9-450C-ADC1-1037F0D979AEQ37601598-D189B568-2512-4571-B24E-6128F48D663BQ37638621-D89882C3-21CB-4B22-AF30-43ED553D44DCQ37656119-15167D02-EE25-4A6A-9B2C-DA8FFC7D58B8Q37718748-99A734E9-849C-4155-8239-87D8571FC8CDQ38168377-C8A6BE03-1D42-404B-B19A-6EDF08F9457FQ38211728-DAA87405-246A-4803-97F9-E365CA031252Q38244304-09ADD4EC-D1A1-4C58-9DB0-77B0F6A453FAQ38262882-97C33DE9-6CE7-4DCD-8274-B70C9B923F6FQ38401187-839BB282-B766-40EA-830E-619A04241653Q38424377-277C9E80-D511-4EC8-987F-DA2202733CE7Q38494691-90903973-2757-4020-8FAF-0E18A68B1C75Q38537257-874FF6AE-657E-4075-B1E4-B0E872E4BB5FQ38676164-009A8DF3-A054-40C2-9ABE-EC14226A62BDQ38694712-C9C7054E-8179-49B9-BC39-BFCB880E0576Q38778869-4D6E9629-F4F4-4654-B5C9-6080A1835181Q38781032-D4D3972D-70BB-44B1-949A-1E7732870CF7Q38796925-E32E8B90-1AE4-4310-A301-BB390C8A6F05Q38801444-1AC617A2-8D8E-4322-9F7F-0CDE33C438BBQ38842836-CF05B547-4AAC-4D53-B26D-009CDACBDC10Q38854139-3C710A51-415E-4E44-8683-4D4F46AFAEB1Q38854207-E08B08E3-84BD-4CE1-92ED-D64B4F8509C4
P2860
Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting receptor-mediated en ...... icles: rationale and advances.
@ast
Targeting receptor-mediated en ...... icles: rationale and advances.
@en
type
label
Targeting receptor-mediated en ...... icles: rationale and advances.
@ast
Targeting receptor-mediated en ...... icles: rationale and advances.
@en
prefLabel
Targeting receptor-mediated en ...... icles: rationale and advances.
@ast
Targeting receptor-mediated en ...... icles: rationale and advances.
@en
P2093
P2860
P1476
Targeting receptor-mediated en ...... icles: rationale and advances.
@en
P2093
Bogdan Z Olenyuk
Curtis T Okamoto
Sarah F Hamm-Alvarez
P2860
P304
P356
10.1016/J.ADDR.2012.09.041
P407
P577
2012-09-29T00:00:00Z